From Health Affairs Today <[email protected]>
Subject Insurance Restrictions Of Buprenorphine
Date May 23, 2023 8:04 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Podcast: Brady Post on Health Care Consolidation
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌


Problems viewing this email?

View Message In Browser
<[link removed]>

Tuesday, May 23, 2023 | The Latest Research, Commentary, And News From
Health Affairs

Dear John,

To mark Insider's one-year anniversary, enjoy $40 off Insider or
Unlimited for new members!

Use discount code InsiderAtOne
<[link removed]>.


Insurance Restrictions Of Buprenorphine

Despite its efficacy for treatment of opioid use disorder, barriers to
buprenorphine prescribing persist, including insurance restrictions.

In the May 2023 issue of Health Affairs, Barbara Andraka-Christou and
coauthors investigate formulary files for Medicaid, Medicare Advantage,
and commercial insurance plans to assess changes to prior authorization
requirements and quantity limits
<[link removed]>
for immediate-release and extended-release buprenorphine from 2017 to
2021 by insurer type.

They find "decreasing prior authorization requirements for buprenorphine
in recent years, with only a small percentage of formularies still
requiring prior authorization."

Among Medicaid and commercial insurers, quantity limits for
immediate-release buprenorphine were relatively rare.

However, "approximately half of Medicare Advantage formularies had
quantity limits on immediate-release buprenorphine tablets" with the
proportion of formularies with quantity limits increasing from 2017 to
2021.

For a full discussion of their findings
<[link removed]>
and the broader implications, read Andraka-Christou and coauthors full
article today.

Read More
<[link removed]>


 

[link removed]


Elsewhere At Health Affairs

Today in Forefront, Dalton Haslam appeals to eliminate observation
status for pediatric patients
<[link removed]>.


They write that this status is a "perfect example of how health
insurance rules can have unintended and harmful consequences for
patients and their families."

Advertise with Health Affairs this month to take advantage of our
current promotions. Learn more about advertising opportunities here.
<[link removed]>

Daily Digest

Buprenorphine Treatment For Opioid Use Disorder: Comparison Of Insurance
Restrictions, 2017-21
<[link removed]>

Barbara Andraka-Christou et al.

Eliminating Observation Status in Pediatrics: An Ethical Appeal
<[link removed]>
Dalton Haslam

[link removed]


Brady Post on the Considerable Relationship Between Consolidation and
Health Care Treatment Intensity

Alan Weil interviews Brady Post from Northeastern University on his
recently published paper examining differences in care among patients
treated by cardiologists who are either practicing independently or as
part of a hospital system.

Listen
<[link removed]>


 

[link removed]


During May, we're highlighting influential Asian American, Native
Hawaiian, and Pacific Islander voices and organizations who have made an
impact on health equity and policy.

In a March 2023 article, Jay Varma and coauthors discuss steps that
policy makers can take to strengthen the current system and to prepare
the country for the next pandemic
<[link removed]>.

 

[link removed]


Health Affairs is launching a contest! The premise is simple. Finish the
statement "You're A Health Policy Wonk If..."

We'll share some of the submissions on Forefront in July, and the
first-place winner of the contest will receive a Health Affairs tumbler
and a free Unlimited membership
<[link removed]>
for a year. Submit by May 31
<[link removed]>.


[link removed]

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
<[link removed]> at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org <healthaffairs.org>, Health Affairs Today
<[link removed]>, and Health Affairs Sunday
Update <[link removed]>.  

Project HOPE <[link removed]> is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy <[link removed]>

To unsubscribe from this email, update your email preferences here
<[link removed]>.
_________________

Sent to [email protected]

Unsubscribe:
[link removed]

Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States
Screenshot of the email generated on import

Message Analysis